CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 45 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $816,000 | -32.2% | 150,000 | -62.5% | 0.03% | -45.8% |
Q3 2019 | $1,204,000 | -19.5% | 400,000 | 0.0% | 0.05% | -11.1% |
Q2 2019 | $1,496,000 | -7.0% | 400,000 | 0.0% | 0.05% | -12.9% |
Q1 2019 | $1,608,000 | +9.5% | 400,000 | 0.0% | 0.06% | -10.1% |
Q4 2018 | $1,468,000 | -70.2% | 400,000 | -30.4% | 0.07% | -61.5% |
Q3 2018 | $4,934,000 | -21.9% | 575,000 | 0.0% | 0.18% | -26.3% |
Q2 2018 | $6,314,000 | -4.8% | 575,000 | 0.0% | 0.24% | -14.1% |
Q1 2018 | $6,630,000 | +51.4% | 575,000 | +36.1% | 0.28% | +42.2% |
Q4 2017 | $4,378,000 | -35.0% | 422,600 | 0.0% | 0.20% | -36.0% |
Q3 2017 | $6,736,000 | +31.7% | 422,600 | 0.0% | 0.31% | +20.5% |
Q2 2017 | $5,113,000 | -41.7% | 422,600 | 0.0% | 0.26% | -49.0% |
Q1 2017 | $8,777,000 | +36.4% | 422,600 | -6.1% | 0.51% | +17.4% |
Q4 2016 | $6,435,000 | -13.1% | 450,000 | 0.0% | 0.43% | -7.1% |
Q3 2016 | $7,403,000 | +15.4% | 450,000 | 0.0% | 0.46% | -2.3% |
Q2 2016 | $6,417,000 | -3.1% | 450,000 | -1.5% | 0.48% | -14.4% |
Q1 2016 | $6,625,000 | – | 456,887 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $28,105,000 | 4.42% |
Novo Holdings A/S | 4,420,516 | $37,928,000 | 3.01% |
BVF INC/IL | 1,890,507 | $16,221,000 | 1.42% |
Orbimed Advisors | 5,967,584 | $51,202,000 | 0.62% |
COWEN INC. | 588,706 | $5,051,000 | 0.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,000 | $710,000 | 0.34% |
SPHERA FUNDS MANAGEMENT LTD. | 321,430 | $2,758,000 | 0.32% |
EcoR1 Capital, LLC | 351,401 | $3,015,000 | 0.27% |
Rock Springs Capital Management LP | 575,000 | $4,934,000 | 0.18% |
Hikari Power Ltd | 32,090 | $275,000 | 0.03% |